Dr. Jean M. Elwing, MD

Dr. Elwing practices at UC Medical Center in Cincinnati, Ohio.

Dr. Elwing's NPI, 1164503355, was assigned on October 17, 2006. Dr. Elwing graduated from Saint Louis University School Of Medicine in 1997. Dr. Elwing holds Ohio license 35.082870.

Dr. Elwing's primary practice is UC Medical Center, at 3188 Bellevue Ave, Cincinnati, OH 45219 in Hamilton County. The practice phone is (513) 584-1000.

Dr. Elwing's primary practice is UC Medical Center in Cincinnati, Ohio. Dr. Elwing is also affiliated with Bethesda North Hospital. The medical group on file is University of Cincinnati Physicians. Dmand AI also links Dr. Elwing to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Elwing practices, 4 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Elwing's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Elwing is board certified in pulmonary disease by the American Board of Internal Medicine. Dr. Elwing is licensed in Ohio.

Dmand AI lists acute respiratory failure, asthma, chronic lung disease, chronic respiratory failure, lung disease: COPD, asthma or bronchitis, pulmonary heart disease and tobacco use among the conditions Dr. Elwing treats.

CMS data shows 673 Medicare services from Dr. Elwing across 9 procedure codes in 2024, for 205 Medicare patients. Medicare paid $39,555 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 205 Medicare patients who saw Dr. Elwing in 2024. The largest group is 65 to 74, with 100 patients. 75% of them have high blood pressure, and 69% have high cholesterol. 17% are also on Medicaid. Their average risk score is 2.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Elwing's median patient age at 61, with 72% women.

In 2024, Dr. Elwing wrote 5,746 Medicare Part D claims for 347 patients. 57% of them were for generic drugs. CMS names the drug for 5,474 of them, across 49 drugs with 11 or more claims each, at $33,354,701 in total drug cost. In 2023, CMS named 4,874 claims across 51 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Elwing for performance year 2024, reported as part of a group. Dr. Elwing accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Elwing as offering telehealth.

Dmand AI links 50 papers to Dr. Elwing, published from 2013 to 2025. 2022 was the busiest year, with 10. The most frequent topics are Hypertension, Pulmonary, Pulmonary Arterial Hypertension and Epoprostenol. Dr. Elwing has published most often in Pulm Circ. Dr. Elwing's most frequent co-authors are Arun Jose, Stephen Carl Mathai, MD, MHS and Vijay Purushoth Balasubramanian, MD.

Dmand AI links Dr. Elwing to 10 clinical trials, 3 of them phase 3 studies. 2 are still active or recruiting. Conditions studied include Pulmonary Arterial Hypertension, Hypertension, Pulmonary and Cryptogenic Organizing Pneumonia. Actelion sponsors the most, 3. Open Payments lists research payments to Dr. Elwing that name 1 trial.

CMS Open Payments shows 557 general payments to Dr. Elwing from 16 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 72% of the total. United Therapeutics Corporation paid the most, $160,204. It also lists 3 research payments totaling $513 from 2017 to 2022, naming 1 clinical trial.

Dmand AI lists 1 award for Dr. Elwing, most recently CMS Stage 1 EHR in 2012.

Dr. Elwing graduated from Saint Louis University School Of Medicine in 1997. Dr. Elwing is a member of ACP.

Dr. Elwing is in network with 20 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 12. Check the plan with the practice before a visit.